Immunoglobulin therapy and quality of life in primary immunodeficiency patients with non-infectious pulmonary complications

This study aims to examine rates of non-infectious pulmonary complications in patients with common variable immunodeficiency (CVID) and the impact of immunoglobulin replacement therapy (IRT) on quality of life (QOL) in this patient subset.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: A. Checkley, S. Kile, L. Kristofek, W. Bolgar, L. Seidu Tags: A251 Source Type: research